Key result
Female sex was independently associated with a higher prevalence of pulmonary hypertension and an increased risk of composite endpoints (HR 1.39; 95% CI 1.02-1.90) in patients with oHCM.
Why the study?
Sex differences in the prevalence and survival impact of pulmonary hypertension in obstructive hypertrophic cardiomyopathy following septal myectomy were unclear.
Are there sex differences in the prevalence and survival of pulmonary hypertension in patients with obstructive hypertrophic cardiomyopathy following septal myectomy?
Cohort (n=1,491)
Are there sex differences in the prevalence and survival of pulmonary hypertension in patients with obstructive hypertrophic cardiomyopathy following septal myectomy?
In patients with obstructive hypertrophic cardiomyopathy following septal myectomy, females have a higher prevalence of pulmonary hypertension and worse overall survival, but within the pulmonary hypertension subgroup, survival is similar between sexes.
Female sex linked to higher PH risk and worse post-myectomy outcomes in obstructive HCM; leaves open need for prospective sex-specific trials.
Background: Pulmonary hypertension (PH) and female have been linked to a worse survival in patients with obstructive hypertrophic cardiomyopathy (oHCM). However, female patients with PH exhibited a better prognosis than males. Herein, we investigated sex differences in the prevalence and survival of pH in oHCM following septal myectomy. Methods: We consecutively enrolled 1491 patients diagnosed with oHCM. PH was defined as a pulmonary artery systolic pressure (PASP) > 36 mm Hg. Results: Females were older, more likely to experience chest pain and NYHA class III/IV symptoms, and had a higher prevalence of PH (37.6 % vs. 19.9 %, p < 0.001) than males. Multivariable analysis showed that female was an independent risk for PH (OR 2.3, 95 % CI: 1.70-3.11, p < 0.001) though the PASP was comparable between males and females (44.93 ± 10.87 vs. 44.74 ± 9.72 mm Hg, p = 0.856). Over a median follow-up of 36 months [IQR 23.5-52.5 months), 28 deaths and 189 composite endpoints were observed. Kaplan-Meier analysis showed a higher cumulative incidence of death (p = 0.015) and composite endpoints (p < 0.001) in patients with PH, and Cox regression analysis revealed that PH (HR 1.78, 95 % CI: 1.30-2.45, p < 0.001) and female (HR 1.39, 95 % CI: 1.02-1.90, p = 0.038) were independently associated with composite endpoints. However, no significant survival differences were found between males and females within the PH subgroup. Conclusions: Female was independently associated with higher prevalence but not severity of PH. Although PH and female were independently associated with worse survival, no survival difference was found between males and females in the PH subgroup.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2024) conducted a cohort in obstructive hypertrophic cardiomyopathy (oHCM) (n=1,491). Female sex vs. Male sex was evaluated on Composite endpoints (HR 1.39, 95% CI 1.02-1.90, p=0.038). Female sex was independently associated with a higher prevalence of pulmonary hypertension and an increased risk of composite endpoints (HR 1.39; 95% CI 1.02-1.90) in patients with oHCM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: